Grovecourt Capital Bets on Healthcare Design Boom with Guide Buy

Grovecourt Capital has partnered with Guide Architecture, a specialized healthcare design firm, betting that the current wave of hospital construction and renovation will sustain demand for architectural expertise through the end of the decade. The Chicago-based private equity firm didn't disclose financial terms, but the deal positions Guide to pursue acquisitions and expand its footprint as healthcare systems race to modernize aging facilities.

The timing isn't accidental. U.S. healthcare construction spending reached $58.3 billion in 2025 — a 12% jump from the prior year — driven by demographic shifts, technology upgrades, and federal incentives tied to rural hospital modernization. Guide, which has built a reputation designing behavioral health units and outpatient centers, is positioned in one of the fastest-growing segments of that market.

What makes this deal notable isn't just the capital infusion. It's the signal that private equity sees durable, scalable economics in a corner of professional services that's historically been fragmented and relationship-driven. Guide operates in nine states with a team of around 80 people — small enough to stay nimble, large enough to compete for seven-figure contracts.

"Healthcare design is experiencing a fundamental shift," said Guide Architecture founder and CEO Michael Hagan in a statement. "Clients aren't just looking for architects — they're looking for partners who understand regulatory complexity, patient outcomes, and operational efficiency." That's consultant-speak for: margins are better when you sell strategy, not just blueprints.

Grovecourt's thesis is straightforward. Healthcare facilities are getting more complex — tighter infection control standards post-pandemic, behavioral health mandates in new construction codes, outpatient surgery centers that need hospital-grade infrastructure but retail-friendly design. That complexity creates barriers to entry and pricing power for firms that know how to navigate it.

The firm previously backed healthcare-adjacent businesses, including medical device distributors and health IT consultancies, but this marks its first move into architecture and engineering services. It's part of a broader trend: professional services firms serving regulated industries — legal, accounting, compliance, now architecture — are increasingly attractive to PE buyers looking for recurring revenue and consolidation opportunities.

Guide's client list includes regional health systems, behavioral health operators, and ambulatory surgery center developers. The firm doesn't design massive academic medical centers — it focuses on the 50,000-to-150,000-square-foot projects that health systems commission in volume. Think behavioral health pavilions, cancer treatment centers, and specialty clinics. Projects in that size range tend to move faster and carry less execution risk than billion-dollar hospital campuses.

The partnership comes as consolidation in healthcare architecture accelerates. Larger firms like HKS and HDR have been acquiring regional players to build national practices. Guide's strategy, backed by Grovecourt, appears to be: grow organically in existing markets while pursuing tuck-in acquisitions of smaller firms with complementary capabilities or geographic reach.

The fundamentals driving healthcare construction spending are stubborn and structural. The U.S. population aged 65 and older is expected to grow by 34% between 2025 and 2040, according to Census Bureau projections. That demographic consumes healthcare services at roughly three times the rate of younger cohorts — and they need facilities designed for mobility challenges, chronic disease management, and longer stays.

At the same time, behavioral health is seeing unprecedented investment. Parity laws, increased insurance coverage for mental health services, and state mandates requiring psychiatric beds in general hospitals have all contributed to a construction boom in behavioral health units. Guide has designed more than 40 behavioral health facilities over the past decade, putting it in the middle of that wave.

Outpatient centers are another growth driver. As reimbursement models shift toward value-based care, health systems are moving procedures out of expensive hospital settings and into lower-cost ambulatory surgery centers and specialty clinics. These facilities require thoughtful design — patient flow, equipment planning, sterile processing — but they're faster to build and easier to finance than traditional hospitals.

Data from Dodge Construction Network shows behavioral health and outpatient projects growing faster than traditional hospital construction — exactly where Guide has concentrated its expertise.

The Infrastructure Investment and Jobs Act and subsequent healthcare-specific appropriations have channeled billions into rural hospital upgrades and community health center expansions. Guide operates in several rural-adjacent markets — Missouri, Oklahoma, Arkansas — where these dollars are landing. Federal grants often require design firms with healthcare specialization and experience navigating CMS facility standards, which narrows the competitive field.

Grovecourt Capital manages roughly $800 million in assets and typically targets lower-middle-market companies with $10 million to $50 million in revenue. The firm's strategy centers on operational improvement and add-on acquisitions — classic buy-and-build. In Guide, they've found a platform with established processes, sticky client relationships, and a leadership team that's been through growth cycles before.

Michael Hagan founded Guide in 2004 and has led the firm through three distinct growth phases: early years focused on community hospitals in the Midwest, expansion into behavioral health during the 2010s, and more recent diversification into outpatient and specialty care. He's staying on as CEO and retaining equity in the business — a signal that this isn't a retirement transaction but a platform build.

The partnership gives Guide access to deal flow that would've been difficult to source independently. Grovecourt has relationships with regional and national healthcare operators, insurance-backed developers, and other portfolio companies that commission architecture work. That's the quiet advantage of PE ownership in professional services: the network effect.

It also provides recruitment firepower. Competing for senior architects and healthcare planners has become brutal as firms expand. Guide can now offer equity participation, clearer growth trajectories, and the resources to compete for larger, more complex projects. For senior hires looking at offers from publicly traded firms like AECOM or private competitors like CannonDesign, that matters.

One risk: cultural integration. Architecture firms, especially those built around healthcare specialization, pride themselves on expertise and client intimacy. Private equity ownership can introduce metrics-driven management that feels alien to professionals trained to prioritize design quality and regulatory compliance over quarterly EBITDA targets. How Grovecourt navigates that tension will determine whether the partnership delivers the growth both sides expect.

Guide operates in nine states, concentrated in the Midwest and South. Logical acquisition targets would be firms with complementary geographic footprints or specialty capabilities — MEP engineering, healthcare planning, interior design. Most of these firms are small: five to twenty people, $2 million to $10 million in revenue, often founder-led with no succession plan.

That's the opportunity. Hundreds of small architecture and engineering firms serving healthcare clients are approaching succession events in the next five years. Many don't have internal buyers or the scale to attract strategic acquirers. Guide, with PE backing and a proven integration model, can offer liquidity and continuity. Whether those deals actually create value depends on integration execution — client retention, staff turnover, and cultural alignment.

The bull case for healthcare architecture rests on sustained construction spending, which depends on hospital operating margins, access to capital, and regulatory tailwinds. All three are showing cracks.

Hospital operating margins have compressed over the past two years as labor costs — particularly nursing and contract staffing — have surged. Many systems are deferring elective capital projects to preserve cash. If that trend accelerates, discretionary projects like outpatient center expansions and specialty clinic builds could slow faster than the headline construction numbers suggest.

Interest rates matter, too. Healthcare construction projects are typically financed with tax-exempt bonds or long-term commercial debt. Even with recent Fed cuts, borrowing costs remain elevated relative to the 2010s. Projects that penciled at 3% financing don't always work at 5.5%. That's already showing up in delayed groundbreakings and scaled-back scopes.

Regulatory risk is harder to quantify but real. Changes to CMS reimbursement policies, certificate-of-need laws, or facility standards can accelerate or kill entire categories of construction. Behavioral health, for instance, has benefited from policy tailwinds for a decade. A shift in priorities — say, toward home-based care or telehealth — could redirect capital away from bricks-and-mortar projects.

Architecture firms are facing their own staffing crisis. The number of newly licensed architects in the U.S. has been flat for a decade while demand for healthcare specialists has surged. Guide will need to recruit aggressively — and likely pay premium compensation — to support growth. That puts pressure on margins and makes organic expansion slower and more expensive than the pitch deck probably suggests.

There's also competition from non-traditional players. Large general contractors are building in-house design teams to capture more of the project value chain. Design-build firms can offer clients single-source accountability, which is appealing in complex healthcare projects. Guide's differentiation — deep clinical expertise, regulatory fluency, patient-centered design — needs to stay sharp as the competitive landscape shifts.

Professional services have become a favorite hunting ground for lower-middle-market PE firms. The playbook is well-worn: acquire a founder-led firm with recurring client relationships, professionalize operations, pursue add-on acquisitions, exit to a larger PE firm or strategic buyer in three to five years.

What's changed is the sectors getting attention. A decade ago, it was IT services and management consulting. Five years ago, it was compliance and regulatory advisory. Now it's specialized professional services tied to regulated industries with structural growth drivers — healthcare architecture, environmental engineering, pharma consulting.

Guide fits that profile exactly. The business isn't capital-intensive, it generates predictable cash flow, and it operates in a market with clear demand drivers and fragmentation. The risk is that everyone sees the same opportunity. If a dozen PE-backed architecture firms are all chasing the same regional targets and competing for the same senior talent, multiples rise, integration gets harder, and returns compress.

The table above shows recent PE investments in healthcare-focused architecture and engineering firms. The pattern is clear: firms with specialized capabilities in high-growth niches are getting backing, and they're being positioned as consolidation platforms.

The question for Guide and Grovecourt is whether they can move fast enough to build a defensible platform before the market gets crowded. That means closing acquisitions, retaining key staff, and winning larger contracts — all while maintaining the design quality and client service that justified the investment thesis in the first place.

Guide will likely announce its first acquisition within 12 to 18 months — that's the typical timeline for PE-backed platforms to validate the buy-and-build model. Targets will probably be small firms in adjacent markets: Memphis, Nashville, Kansas City, markets where Guide has relationships but no permanent presence.

The firm will also need to demonstrate organic growth. That means expanding service offerings — adding healthcare planning, interior design, or construction administration — and winning larger projects that showcase its ability to compete with national firms. Behavioral health will remain core, but diversification into outpatient and specialty care will be critical to de-risking the revenue base.

For Grovecourt, this deal signals a deeper commitment to healthcare services. The firm has capital to deploy and a network of healthcare operators who need design, engineering, and consulting services. Guide could become a platform for broader healthcare services consolidation — adding MEP engineering, medical planning, equipment procurement — or it could stay focused on architecture and design. That strategic decision will shape the next fundraising cycle and the eventual exit.

Competitors are watching. Smaller healthcare architecture firms without succession plans now have a template: build a specialized practice, demonstrate recurring revenue, attract PE capital, consolidate. Larger firms with national footprints might accelerate their own M&A activity to lock up regional talent and client relationships before PE-backed competitors can.

The healthcare design market is big enough to support multiple winners, but it's also relationship-driven and locally entrenched. Grovecourt and Guide are betting that capital, process, and scale can overcome those traditional advantages. Whether that bet pays off depends on execution — and on whether the underlying demand for healthcare construction holds up through the next economic cycle.

Private equity thrives on businesses with repeatable processes, predictable margins, and opportunities for operational leverage. Healthcare architecture has some of those characteristics — recurring clients, defined project phases, regulatory expertise that creates pricing power. But it also has characteristics that resist scaling: projects are bespoke, senior talent is scarce, and client relationships are deeply personal.

The test for Grovecourt and Guide will be whether they can industrialize enough of the business to generate PE-level returns without losing the creativity and client intimacy that make healthcare architecture valuable in the first place. That's a tension every PE-backed professional services firm faces — and not all of them solve it.

If Guide can thread that needle — maintaining design excellence while building a scalable, acquisitive platform — this partnership will be studied as a model for how to bring PE discipline to creative professional services. If it can't, it'll be another cautionary tale about the limits of financialization in industries built on expertise and trust.

For now, the market conditions are favorable, the thesis is sound, and the team has the experience to execute. What comes next will depend on how well they navigate the gap between the spreadsheet and the sketch.